No profile data available.
MediciNova, Inc. (MNOV) is a healthcare company in the brain and nerve treatment drugs industry, based in La Jolla, United States, with about 6 full-time employees.
It reported revenue of $409,657 for fiscal year 2025, and net income of -$12.00 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $458,439, up 240.6% from a year before. Its market capitalization was $74.82 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
MediciNova reported $409,657 in revenue for fiscal year 2025. In Q2 2026 revenue was $458,439.
$74.82 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Neumora Therapeutics, Inc. (NMRA), ProMIS Neurosciences, Inc. (PMN), Cognition Therapeutics, Inc. (CGTX), Gain Therapeutics, Inc. (GANX).